Alzheimer's Disease
|
OPPORTUNITY NUMBER |
OPPORTUNITY TITLE |
AGENCY NAME |
POSTED DATE |
CLOSE DATE |
| PAR-21-308 | Pragmatic Trials for Dementia Care and Caregiver Support (R61/R33 Clinical Trial Required) | HHS-NIH11 | 08/11/2021 | 02/13/2024 |
| PAR-21-307 | Dementia Care and Caregiver Support Intervention Research (R01 Clinical Trial Required) | HHS-NIH11 | 08/11/2021 | 02/13/2024 |
| RFA-AG-22-024 | Primary Care-Based Screening and Intervention Development for Prevention of Abuse in Older and Vulnerable Adults in the Context of Alzheimers Disease and Related Dementias (R61/R33 Clinical Trial Required) | HHS-NIH11 | 07/15/2021 | 10/20/2021 |
| RFA-AG-22-021 | Elucidating the Roles of Transposable Elements in AD/ADRD and Aging (R01 Clinical Trial Not Allowed) | HHS-NIH11 | 07/14/2021 | 11/02/2021 |
| RFA-AG-22-025 | Data Enhancements and Analyses to Clarify the Relationship between Education and Cognitive Function (including AD/ADRD) (R01 Clinical Trial Not Allowed) | HHS-NIH11 | 06/23/2021 | 10/20/2021 |
| RFA-AG-22-025 | Data Enhancements and Analyses to Clarify the Relationship between Education and Cognitive Function (including AD/ADRD) (R01 Clinical Trial Not Allowed) | HHS-NIH11 | 06/23/2021 | 10/20/2021 |
| RFA-AG-22-017 | Role of Adaptive Immunity in Etiology of Alzheimers Disease and Alzheimers Disease-Related Dementias (R01 Clinical Trial Optional) | HHS-NIH11 | 06/16/2021 | 10/28/2021 |
| RFA-AG-22-003 | NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurship Enhancement Award (R25 Clinical Trial Not Allowed) | HHS-NIH11 | 06/10/2021 | 10/04/2021 |
| RFA-AG-22-019 | High Resolution Mapping of Biomolecules in Brain Cells in Aging and Alzheimers Disease (R01 Clinical Trial Not Allowed) | HHS-NIH11 | 06/10/2021 | 10/28/2021 |
| PAR-21-217 | NIA Postdoctoral Fellowship Award to Promote Diversity in Translational Research for AD/ADRD (F32 Clinical Trial Not Allowed) | HHS-NIH11 | 05/28/2021 | 08/08/2024 |
| PAR-21-220 | NIA Advanced Postdoctoral Career Transition Awards to Promote Diversity in Translational Research for AD/ADRD (K99/R00 Clinical Trial Not Allowed) | HHS-NIH11 | 05/28/2021 | 05/07/2024 |
| PAR-21-218 | NIA Predoctoral Fellowship Award to Promote Diversity in Translational Research for AD/ADRD (F31) | HHS-NIH11 | 05/28/2021 | 08/08/2024 |
| RFA-AG-22-016 | Mechanism-Focused Research to Promote Adherence to Healthful Behaviors to Prevent Mild Cognitive Impairment (MCI) and Alzheimers Disease and Related Dementias (AD/ADRD) (R61/R33 Clinical Trial Required) | HHS-NIH11 | 04/06/2021 | 09/15/2021 |
| PAR-21-207 | Mechanism-Focused Research to Promote Adherence to Healthful Behaviors to Prevent Mild Cognitive Impairment (MCI) and Alzheimers Disease and Related Dementias (AD/ADRD) (R01 Clinical Trial Optional) | HHS-NIH11 | 04/06/2021 | 01/26/2022 |
| RFA-AG-22-010 | Short Courses on Interdisciplinary Behavioral and Social Sciences Research on Alzheimer's Disease and Related Dementias (R25 - Clinical Trial Not Allowed) | HHS-NIH11 | 03/23/2021 | 10/04/2021 |
| PAR-21-112 | Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (T32) | HHS-NIH11 | 01/22/2021 | 09/25/2023 |
| PAR-20-309 | Alzheimer's Clinical Trials Consortium (ACTC) Clinical Trials (R01 Clinical Trial Required) | HHS-NIH11 | 11/24/2020 | 01/07/2024 |
| PAR-20-157 | Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R01 Clinical Trial Optional) | NIH | 03/31/2020 | 05/07/2023 |
| PAR-20-159 | Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R21 Clinical Trial Optional) | NIH | 03/31/2020 | 05/07/2023 |
| PAR-20-156 | Translational Bioinformatics Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease (R01 Clinical Trial Optional) | NIH | 03/31/2020 | 05/07/2023 |
| PAR-20-110 | National Institute on Aging Genetics of Alzheimer's Disease Data Storage Site (U24 Clinical Trial Not Allowed) | NIH | 02/07/2020 | 01/25/2023 |
| PAR-20-081 | Mechanisms of Disparities in Chronic Liver Diseases and Cancer (R21- Clinical Trial Not Allowed) | NIH | 01/14/2020 | 04/01/2022 |
| PAR-20-088 | Mechanisms of Disparities in Chronic Liver Diseases and Cancer (R01- Clinical Trial Not Allowed) | NIH | 01/14/2020 | 04/01/2022 |
| PAR-20-055 | Engineering Next-Generation Human Nervous System Microphysiological Systems (R01 Clinical Trials Not Allowed) | NIH | 01/03/2020 | 01/07/2023 |
| PAR-20-082 | Engineering Next-Generation Human Nervous System Microphysiological Systems (R21 Clinical Trials Not Allowed) | NIH | 01/03/2020 | 01/07/2023 |
| RFA-NS-20-006 | BRAIN Initiative: Biology and Biophysics of Neural Stimulation and Recording Technologies (R01 Clinical Trials Optional) | NIH | 01/02/2020 | 10/03/2022 |
| PAR-20-055 | Engineering Next-Generation Human Nervous System Microphysiological Systems (R01 Clinical Trials Not Allowed) | NIH | 01/03/2020 | 01/07/2023 |
| PAR-20-082 | Engineering Next-Generation Human Nervous System Microphysiological Systems (R21 Clinical Trials Not Allowed) | NIH | 01/03/2020 | 01/07/2023 |
| RFA-NS-20-006 | BRAIN Initiative: Biology and Biophysics of Neural Stimulation and Recording Technologies (R01 Clinical Trials Optional) | NIH | 01/02/2020 | 10/03/2022 |
| PAR-20-078 | Secondary Analysis of Existing Datasets in Heart, Lung, and Blood Diseases and Sleep Disorders (R21 Clinical Trial Not Allowed) | NIH | 12/19/2019 | 11/25/2022 |
| PAR-20-075 | Limited Competition: NIDDK Program Projects (P01 Clinical Trial Optional) | NIH | 12/11/2019 | 01/07/2023 |
| PAR-20-072 | NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed) | NIH | 12/09/2019 | 09/07/2022 |
| PAR-20-063 | NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed) | NIH | 11/22/2019 | 01/07/2023 |
| PAR-20-045 | NIDCR Research Grants for Analyses of Existing Genomics Data (R01 Clinical Trial Not Allowed) | NIH | 11/08/2019 | 01/07/2023 |
| PAS-19-391 | Small Research Grant Program for the Next Generation of Clinical Researchers in AD/ADRD Research: Area of Focus Archiving and Leveraging Existing Data Sets for Analyses (R03 Clinical Trial Not Allowed) | NIH | 10/07/2019 | 11/16/2022 |
| PAS-19-392 | Small Research Grant Program for the Next Generation of Clinical Researchers in AD/ADRD Research: Area of Focus Basic Science (R03 Clinical Trials Not Allowed) | NIH | 10/07/2019 | 11/16/2022 |
| PAS-19-393 | Small Research Grant Program for the Next Generation of Clinical Researchers in AD/ADRD Research: Area of Focus Systems Biology (R03 Clinical Trial Not Allowed) | NIH | 10/07/2019 | 11/16/2022 |
| PAR-19-372 | Social Epigenomics Research Focused on Minority Health and Health Disparities (R01-Clinical Trial Not Allowed) | NIH | 09/10/2019 | 11/08/2022 |
| PAR-19-365 | Limited Competition: Small Grant Program for NIDDK K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional) | NIH | 09/09/2019 | 09/07/2022 |
| PAR-19-346 | Investigations on Primary Immunodeficiency Diseases/Inborn Errors of Immunity (R21 Clinical Trial Not Allowed) | NIH | 08/16/2019 | 09/07/2022 |
| PAR-19-347 | Investigations on Primary Immunodeficiency Diseases/Inborn Errors of Immunity (R03 Clinical Trial Not Allowed) | NIH | 08/16/2019 | 07/16/2022 |
| PAR-19-307 | Mechanisms of Mycobacterial-Induced Immunity in HIV-Infected and/or Uninfected Individuals to Inform Innovative Tuberculosis Vaccine Design (R01 Clinical Trial Not Allowed) | NIH | 06/28/2019 | 01/14/2022 |
| PAR-19-305 | Early-Stage T1 Translational Aging Research (Bench to Bedside) for the Development of Novel Therapeutics (R21/R33 Clinical Trial Optional) | NIH | 06/25/2019 | 07/16/2022 |
| PAR-19-304 | Early-Stage T1 Translational Aging Research (Bench to Bedside) for the Development of Novel Therapeutics (R33 Clinical Trial Optional) | NIH | 06/25/2019 | 07/16/2022 |
| PAR-19-298 | Non-Invasive Neurostimulation in AD/ADRD (R01 Clinical Trial Optional) | NIH | 06/14/2019 | 09/07/2022 |
| PAR-19-294 | Early-Stage Preclinical Validation of Therapeutic Leads for Diseases of Interest to the NIDDK (R01 Clinical Trial Not Allowed) | NIH | 06/06/2019 | 11/12/2021 |
| PAR-19-293 | Development of Novel and Robust Systems for Mechanistic Studies of Gene-Environment Interplay in Dental, Oral, Craniofacial, and Other Diseases and Conditions (R21 Clinical Trial Not Allowed) | NIH | 06/05/2019 | 09/07/2022 |
| PAR-19-292 | Mechanistic Studies of Gene-Environment Interplay in Dental, Oral, Craniofacial, and Other Diseases and Conditions (R01 Clinical Trial Not Allowed) | NIH | 06/05/2019 | 09/07/2022 |
| PAR-19-276 | Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed) | NIH | 05/08/2019 | 05/07/2022 |
| PAR-19-275 | Dissemination and Implementation Research in Health (R21 Clinical Trial Optional) | NIH | 05/08/2019 | 05/07/2022 |
| PAR-19-274 | Dissemination and Implementation Research in Health (R01 Clinical Trial Optional) | NIH | 05/08/2019 | 05/07/2022 |
| PAR-19-264 | Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Aggressive Cancer (R01 Clinical Trial Optional) | NIH | 05/01/2019 | 12/10/2021 |
| PAS-19-241 | Stimulating Urology Interdisciplinary Team Opportunity Research (SUITOR) (R01 Clinical Trial Optional) | NIH | 04/05/2019 | 05/07/2022 |
| PAR-19-239 | Clinical Research to Improve the Oral Health of Older Adults (R01 Clinical Trial Not Allowed) | NIH | 04/04/2019 | 09/06/2022 |
| PAR-19-240 | Clinical Research to Improve the Oral Health of Older Adults (R21 Clinical Trial Not Allowed) | NIH | 04/04/2019 | 09/07/2022 |
| PAR-19-222 | Small Grants for New Investigators to Promote Diversity in Health-Related Research (R21 Clinical Trial Optional) | NIH | 03/18/2019 | 05/07/2022 |
| PAS-19-210 | Progression Markers for Cognitive Impairment in Parkinson's Disease Dementia (R01 Clinical Trial Not Allowed) | NIH | 03/05/2019 | 05/07/2022 |
| PAR-19-202 | High impact, Interdisciplinary Science in NIDDK Research Areas (RC2 Clinical Trial Optional) | NIH | 02/27/2019 | 11/02/2021 |
| PAR-19-173 | Achieving Tissue Robustness Through Harnessing Immune System Plasticity (R21 Clinical Trial Not Allowed) | NIH | 01/29/2019 | 05/07/2022 |
| PAR-19-172 | Achieving Tissue Robustness Through Harnessing Immune System Plasticity (R01 Clinical Trial Not Allowed) | NIH | 01/29/2019 | 05/07/2022 |
| PA-19-166 | Implementation of shared decision making for HLBS diseases and conditions (R01 Clinical Trial Optional) | NIH | 01/22/2019 | 05/07/2022 |
| PAR-19-173 | Achieving Tissue Robustness Through Harnessing Immune System Plasticity (R21 Clinical Trial Not Allowed) | NIH | 01/29/2019 | 05/07/2022 |
| PAR-19-172 | Achieving Tissue Robustness Through Harnessing Immune System Plasticity (R01 Clinical Trial Not Allowed) | NIH | 01/29/2019 | 05/07/2022 |
| PAR-19-153 | End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses (R21 Clinical Trial Optional) | NIH | 01/08/2019 | 01/07/2022 |
| PAR-19-137 | NIDCD Clinical Research Center Grant (P50 Clinical Trial Optional) | NIH | 12/26/2018 | 10/06/2021 |
| PAR-19-136 | End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses (R01 Clinical Trial Optional) | NIH | 12/21/2018 | 01/07/2022 |
| PA-19-125 | Mentored Quantitative Research Development Award (Parent K25 - Independent Clinical Trial Required) | NIH | 12/20/2018 | 01/07/2022 |
| PA-19-124 | Mentored Quantitative Research Development Award (Parent K25 - Independent Clinical Trial Not Allowed) | NIH | 12/20/2018 | 01/07/2022 |
| PAS-19-105 | Stimulating Hematology Investigation: New Endeavors (SHINE) (R01 Clinical Trial Not Allowed) | NIH | 12/17/2018 | 01/07/2022 |
| PA-19-096 |
Control of Sexually Transmitted Infections (STIs) Through a Comprehensive Understanding of the Natural History of Infection (R01 Clinical Trial Not Allowed) | NIH | 11/29/2018 | 1/7/2022 |
| PA-19-089 |
Mentored Quantitative Research Development Award (Parent K25 - Independent Basic Experimental Studies with Humans Required) | NIH | 11/28/2018 | 1/7/2022 |
| PA-19-082 |
Novel approaches to understand, prevent, treat, and diagnose coccidioidomycosis (Valley Fever) and other select endemic fungal infections (R01 Clinical Trial Not Allowed) | NIH | 11/26/2018 | 1/7/2022 |
| PA-19-083 |
Novel approaches to understand, prevent, treat, and diagnose coccidioidomycosis (Valley Fever) and other select endemic fungal infections (R21 Clinical Trial Not Allowed) | NIH | 11/26/2018 | 1/7/2022 |
| PA-19-077 |
Accelerating Malaria Vaccine Discovery (R01 Clinical Trial Not Allowed) | NIH | 11/26/2018 | 1/7/2022 |
| PAR-19-079 |
Molecular and Genetic Characterization of Inborn Errors of Immunity (R21 Clinical Trial Not Allowed) | NIH | 11/26/2018 | 1/7/2022 |
| PAR-19-078 |
Molecular and Genetic Characterization of Inborn Errors of Immunity (R01 Clinical Trial Not Allowed) | NIH | 11/26/2018 | 1/7/2022 |
| PA-19-073 |
Telomeres in Wellness and Disease: A Biobehavioral Approach (R21 Clinical Trial Optional) | NIH | 11/20/2018 | 1/7/2022 |
| PA-19-074 |
Telomeres in Wellness and Disease: A Biobehavioral Approach (R01 Clinical Trial Optional) | NIH | 11/20/2018 | 1/7/2022 |
| PAR-19-070 |
Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional) | NIH | 11/16/2018 | 11/12/2021 |
| PAR-19-071 |
Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Not Allowed) | NIH | 11/16/2018 | 11/12/2021 |
| PA-19-068 |
Secondary Analysis of Existing Datasets for Advancing Infectious Disease Research (R21 Clinical Trial Not Allowed) | NIH | 11/13/2018 | 1/7/2022 |
| PA-19-066 |
Processing and Presentation of Non-Conventional MHC Ligands (R21 Clinical Trial Not Allowed) | NIH | 11/13/2018 | 1/7/2022 |
| PA-19-067 |
Processing and Presentation of Non-Conventional MHC Ligands (R01 Clinical Trial Not Allowed) | NIH | 11/13/2018 | 1/7/2022 |
| PA-18-907 | New Computational Methods for Understanding the Functional Role of DNA Variants that are Associated with Mental Disorders (R01 (Collab) Clinical Trial Not Allowed) | NIH | 8/29/2018 | 1/7/2022 |
| PA-18-908 | New Computational Methods for Understanding the Functional Role of DNA Variants that are Associated with Mental Disorders (R01 Clinical Trial Not Allowed) | NIH | 8/29/2018 | 1/7/2022 |
| PA-18-906 | Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) | NIH | 8/22/2018 | 9/7/2021 |
| PA-18-903 | Pilot and Feasibility Clinical and Translational Research Studies in Digestive Diseases and Nutrition (R21 Clinical Trial Optional) | NIH | 8/14/2018 | 9/7/2021 |
| PAR-18-892 | Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R21 Clinical Trial Optional) | NIH | 8/7/2018 | 9/7/2021 |
| PAR-18-893 | Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R01 Clinical Trial Optional) | NIH | 8/7/2018 | 9/7/2021 |
| PAR-18-877 | Early Stage Clinical Trials for the Spectrum of Alzheimers Disease and Age-related Cognitive Decline (R01 Clinical Trial Optional) | NIH | 7/26/2018 | 9/7/2021 |
| PAR-18-878 | Late Stage Clinical Trials for the Spectrum of Alzheimers Disease and Age-related Cognitive Decline (R01 Clinical Trial Required) | NIH | 7/26/2018 | 9/7/2021 |
| PA-18-874 | Biologic Factors Underlying Dental, Oral, and Craniofacial Health Disparities (R21 - Clinical Trial Not Allowed) | NIH | 7/25/2018 | 9/7/2021 |
| PA-18-876 | Advancing Mechanistic Probiotic/Prebiotic and Human Microbiome Research (R01 Clinical Trial Not Allowed) | NIH | 7/25/2018 | 9/7/2021 |
| PAR-18-875 | Biologic Factors Underlying Dental, Oral, and Craniofacial Health Disparities (R01 - Clinical Trial Not Allowed) | NIH | 7/25/2018 | 9/7/2021 |
| PA-18-873 | Research to Advance Vaccine Safety (R01 Clinical Trial Not Allowed) | NIH | 7/24/2018 | 9/7/2021 |
| PA-18-872 | Research to Advance Vaccine Safety (R21 Clinical Trial Not Allowed) | NIH | 7/24/2018 | 9/7/2021 |
| PAR-18-843 | Investigator Initiated Research in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed) | NIH | 6/28/2018 | 9/7/2021 |
| PA-18-838 | Role of Gut Microbiome in Regulating Reproduction and Its Impact on Fertility Status in Women Living with and Without HIV (R01 - Clinical Trial Optional) | NIH | 6/26/2018 | 9/7/2021 |
| PA-18-839 | Role of Gut Microbiome in Regulating Reproduction and Its Impact on Fertility Status in Women Living with and Without HIV (R21 Clinical Trial Optional) | NIH | 6/26/2018 | 9/7/2021 |
| Accelerating Basic and Translational Research in Hidradenitis Suppurativa (R21 Clinical Trial Not Allowed) |
NIH |
3/28/2018 |
9/7/2021 |
|
| Accelerating Basic and Translational Research in Hidradenitis Suppurativa (R01 Clinical Trial Not Allowed) |
NIH |
3/28/2018 |
9/7/2021 |
|
| Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) |
NIH |
1/24/2018 |
9/7/2021 |